Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles

International Journal of Pharmaceutics

Volumn 301, Issue 1-2, 2005, Pages 149-160

  Katare, Yogesh K ^a   Muthukumaran, T ^a   Panda, Amulya K ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

Antibody response; Antigen load; Particle size; PLA particles; Tetanus toxoid

Indexed keywords

ALUMINUM POTASSIUM SULFATE; POLYLACTIDE; TETANUS ANTIBODY; TETANUS TOXOID;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SURFACE PROPERTY; TETANUS; TETANUS PROPHYLAXIS;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; POLYESTERS; RATS; RATS, WISTAR; SURFACE PROPERTIES; TETANUS TOXOID;

EID: 23944462440     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.05.028     Document Type: Article

References (49)

1. G. Boehm, M. Peyre, D. Sesardic, R.J. Huskisson, F. Mawas, A. Douglas, D. Xing, H.P. Merkle, B. Gander, and P. Johansen On technological and immunological benefits of multivalent single-injection microsphere vaccines Pharm. Res. 19 2002 1330 1336
2. J.M. Brewer, K.G. Pollock, L. Tetley, and D.G. Russell Vesicle size influences the trafficking, processing, and presentation of antigens in lipid vesicles J. Immunol. 173 2004 6143 6150
3. A.M. Carcaboso, R.M. Hernandez, M. Igartua, J.E. Rosas, M.E. Patarroyo, and J.L. Pedraz Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles Vaccine 22 2004 1423 1432
4. A.M. Carcaboso, R.M. Hernandez, M. Igartua, J.E. Rosas, M.E. Patarroyo, and J.L. Pedraz Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines: single intradermal administration Pharm. Res. 21 2004 121 126
5. J.L. Cleland Single-administration vaccines: controlled-release technology to mimic repeated immunizations Trends Biotechnol. 17 1999 25 29
6. A.G. Coombes, E.C. Lavelle, P.G. Jenkins, and S.S. Davis Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen Vaccine 14 1996 1429 1438
7. M.P. Desai, V. Labhasetwar, G.L. Amidon, and R.J. Levy Gastrointestinal uptake of biodegradable microparticles: effect of particle size Pharm. Res. 13 1996 1838 1845
8. M. Diwan, R.K. Khar, and G.P. Talwar Tetanus toxoid loaded preformed microsphere of cross-linked dextran Vaccine 19 2001 3853 3859
9. I. Esparza, and T. Kissel Parameters affecting the immunogenicity of microencapsulated tetanus toxoid Vaccine 10 1992 714 720
10. T. Fifis, A. Gamvrellis, B. Crimeen-Irwin, G.A. Pietersz, J. Li, P.L. Mottram, I.F. McKenzie, and M. Plebanski Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors J. Immunol. 173 2004 3148 3154
11. R.K. Gupta, M. Singh, and D.T. O'Hagan Poly(lactide-co-glycolide) microparticles for the development of single dose controlled-release vaccines Adv. Drug Del. Rev. 32 1998 225 246
12. I. Gutierro, R.M. Hernandez, M. Igartua, A.R. Gascon, and J.L. Pedraz Influence of dose and immunization route on the serum IgG antibody response to BSA loaded PLGA microspheres Vaccine 20 2002 2181 2190
13. I. Gutierro, R.M. Hernandez, M. Igartua, A.R. Gascon, and J.L. Pedraz Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres Vaccine 21 2002 67 77
14. J. Hanes, J.L. Cleland, and R. Langer New advances in microsphere-based single dose vaccines Adv. Drug Del. Rev. 28 1997 97 119
15. A.K. Hilbert, U. Fritzsche, and T. Kissel Biodegradable microspheres containing influenza A vaccine: immune response in mice Vaccine 17 1999 1065 1073
16. E. Horisawa, K. Kubota, I. Tuboi, K. Sato, H. Yamamoto, H. Takeuchi, and Y. Kawashima Size-dependency of d,l-lactide/glycolide copolymer particulates for intraarticular delivery system on phagocytosis in rat synovium Pharm. Res. 19 2002 132 139
17. D.W. Howie, B. Menthey, S. Hay, and B.V. Roberts The synovial response to intraarticular injection in rats of polyethylene wear particles Clin. Orthop. 292 1993 352 357
18. M. Igartua, R.M. Hernandez, A. Esquisabel, A.R. Gascon, M.B. Calvo, and J.L. Pedraz Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres J. Control. Rel. 56 1998 63 73
19. P. Johansen, F. Estevez, R. Zurbriggen, H.P. Merkle, R. Gluck, G. Corradin, and B. Gander Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres Vaccine 19 2001 1047 1054
20. P. Johansen, B. Gander, H.P. Merkle, and D. Sesardic Ambiguities in the preclinical quality assessment of microparticulate vaccines Trends Biotechnol. 18 2000 203 211
21. D.H. Jones Microencapsulation of vaccine antigens Meth. Mol. Med. 87 2003 211 222
22. Y.K. Katare, and A.K. Panda Effect of alum on in vitro release profile and immunogenicity of microencapsulated tetanus toxoid Proc. Int. Symp. Control. Rel. Bioact. Mater. 28 2001 1059 1060
23. Y.K. Katare, A.K. Panda, K. Lalwani, I.U. Haque, and M.M. Ali Potentiation of immune response from polymer entrapped antigen: towards the development of single dose tetanus toxoid vaccine Drug Del. 10 2003 231 238
24. G.F.A. Kersten, D. Donders, A. Akkermans, and E.C. Beuveery Single shot with tetanus toxoid in biodegradable polymer microsphere protects mice despite acid induced denaturation of the antigen Vaccine 14 1996 1632 1672
25. J.C. Lee, and S.N. Timasheff The stabilization of proteins by sucrose J. Biol. Chem. 256 1981 7193 7201
26. R. Nakaoka, Y. Inoue, Y. Tabata, and Y. Ikada Size effect on the antibody production induced by biodegradable microspheres containing antigen Vaccine 14 1996 1251 1256
27. K.D. Newman, P. Elamanchili, G.S. Kwon, and J. Samuel Uptake of poly(d,l-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo J. Biomed. Mater. Res. 60 2002 480 486
28. D.T. O'Hagan, H. Jeffery, and S.S. Davis Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles Vaccine 11 1993 965 969
29. J. Panyam, W.Z. Zhou, S. Prabha, S.K. Sahoo, and V. Labhasetwar Rapid endo-lysosomal escape of poly(d,l-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery FASEB J. 16 2002 1217 1226
30. J. Panyam, and V. Labhasetwar Dynamics of endocytosis and exocytosis of poly(d,l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells Pharm. Res. 20 2003 212 220
31. M. Peyre, D. Sesardic, H.P. Merkle, B. Gander, and P. Johansen An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria J. Pharm. Sci. 92 2003 957 966
32. M. Peyre, R. Audran, F. Estevez, G. Corradin, B. Gander, D. Sesardic, and P. Johansen Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions J. Control. Rel. 99 2004 345 355
33. R.S. Raghuvanshi, S. Goyal, Om Singh, and A.K. Panda Stabilization of dichloromethane-induced protein denaturation during microencapsulation Pharm. Dev. Technol. 3 1998 269 276
34. R.S. Raghuvanshi, Om Singh, and A.K. Panda Formulation and characterization of immunoreactive tetanus toxoid biodegradable polymer particles Drug Del. 8 2001 99 106
35. R.S. Raghuvanshi, Y.K. Katare, K. Lalwani, M.M. Ali, O. Singh, and A.K. Panda Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants Int. J. Pharm. 245 2002 109 121
36. S. Raychaudhuri, and K.L. Rock Fully mobilizing host defense: building better vaccines Nat. Biotechnol. 16 1998 1025 1031
37. S.P. Schwendeman Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems Crit. Rev. Ther. Drug Carrier Syst. 19 2002 73 98
38. L. Shi, M.J. Caulfield, R.T. Chern, R.A. Wilson, G. Sanyal, and D.B. Volkin Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres J. Pharm. Sci. 91 2002 1019 1035
39. M. Singh, X.M. Li, J.P. McGee, T. Zamb, W. Koff, C.Y. Wang, and D.T. O'Hagan Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice Vaccine 15 1997 475 481
40. M. Singh, X.M. Li, H. Wang, J.P. McGee, T. Zamb, W. Koff, C.Y. Wang, and D.T. O'Hagan Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single dose vaccine Infect. Immun. 65 1997 1716 1721
41. M.K. Slifka, and R. Ahmed Long-lived plasma cells: a mechanism for maintaining persistent antibody production Curr. Opin. Immunol. 10 1998 252 258
42. C. Srinivasan, Y.K. Katare, T. Muthukumaran, and A.K. Panda Effect of additives on encapsulation efficiency, stability, and bioactivity of entrapped lysozyme from biodegradable polymer particles J. Microencapsul. 22 2005 127 138
43. Y. Tabata, and Y. Ikada Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage Biomaterials 9 1988 356 362
44. Y. Tabata, Y. Inoue, and Y. Ikada Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres Vaccine 14 1996 1677 1685
45. L. Thiele, B. Rothen-Rutishauser, S. Jilek, H. Wunderli-Allenspach, H.P. Merkle, and E. Walter Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? J. Control. Rel. 76 2001 59 71
46. T. Uchida, S. Martin, T.P. Foster, R.C. Wardley, and S. Grimm Dose and load studies for subcutaneous and oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin Pharm. Res. 11 1994 1009 1015
47. T. Uchida, and S. Goto Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study Biol. Pharm. Bull. 17 1994 1272 1276
48. L. Vidard, M. Kovacsovics-Bankowski, S.K. Kraeft, L.B. Chen, B. Benacerraf, and K.L. Rock Analysis of MHC class II presentation of particulate antigens of B-lymphocytes J. Immunol. 156 1996 2809 2818
49. M. Weert van de, W.E. Hennink, and W. Jiskoot Protein instability in poly(lactic-co-glycolic acid) microparticles Pharm. Res. 17 2000 1159 1167